Delivery Order SPE2DB20D2104-SPE2DB26FMBKQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,336.06 for 90 tablets of Livalo 2 mg on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,953.53 to AmerisourceBergen Drug Corp for the supply of Livalo 4 mg tablets (90-count units), with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $2,835.51 to AmerisourceBergen Drug Corp for 90 tablets of Livalo 2 mg, a pharmaceutical product used to manage cholesterol levels. The award was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $2,977.16 and a completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564134891 LIVALO 1 MG TABLET 90S. The contract has a ceiling value of $1,262.90 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,624.90, is for the delivery of 90 tablets of the drug Livalo 2 mg. It is a firm-fixed price delivery order contract with a completion date of June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,564,002,447 units of the pharmaceutical product LIVALO 2 MG TABLET 90S, with a firm fixed price ceiling value of $1,276.84. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contract awards from DLA to supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $545 to Amerisourcebergen Drug Corporation to supply 90 tablets of the pharmaceutical Livalo 2 mg. The order was placed under an existing Amerisourcebergen contract vehicle to fulfill requirements for the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. No subcontractors...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FK5G1) under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. The contract is for the delivery of Livalo 2 mg tablets, a pharmaceutical product, with a ceiling value of $2,114.40 and a performance period ending on August 2, 2022. This award does not have a set-aside designation, indicating...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBKQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Livalo 1 mg tablets (90-count packages) with a ceiling value of $4,675.27. This competitive award, executed as a firm fixed-price delivery order with no set-aside designation, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems and other federal medical procurement needs. The company's role as a pharmaceutical prime vendor reflects its established capability to meet competitive federal procurement standards and deliver critical medications across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 10/30/25 |